Synergistic cell killing by concomitant treatment of lung cancer cell line with arsenic trioxide and histone deacetylase inhibitor
碩士 === 國立陽明大學 === 藥理學研究所 === 96 === The efficacy of arsenic trioxide（ATO, Trisenox®）against acute promyelocytic leukemia（APL）and relapsed acute promyelocytic leukemia has been well-documented. ATO has been approved by Food and Drug Administration（FDA）on September 2000 for treatment of relapsed APL....
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | zh-TW |
| Published: |
2008
|
| Online Access: | http://ndltd.ncl.edu.tw/handle/07575917175648819821 |